Evgenia Gourgari, MD| Pediatric Endocrinology | MedStar Health
Evgenia Gourgari

Evgenia Gourgari, MD
Provider is directly employed by MedStar Health

4.7 out of 5 (112 reviews)

Specialties: Pediatric Endocrinology

Languages: English


About me

Dr. Evgenia Gourgari sees patients at MedStar Georgetown University Hospital, MedStar St. Mary's Hospital and MedStar Montgomery Medical Center in Olney. She is board certified in Pediatrics and Pediatric endocrinology. Call 202-295-0547 to schedule an appointment.

Conditions and procedures

Conditions I treat

  • Abnormal Glucose Metabolism
  • Addison's Disease
  • Adrenal Adenoma
  • Adrenal Atrophy
  • Adrenal Disorders
  • Adrenal Hyperplasia
  • Adrenal Mass
  • Adrenal Neoplasm
  • Adrenogenital Syndrome
  • Androgen Excess
  • Androgen Insensitivity
  • Calcium Metabolism
  • Congenital Adrenal Hyperplasia
  • Congenital Hypothyroidism
  • Cushing Syndrome
  • Delayed Puberty
  • Diabetes Insipidus
  • Diabetes Mellitus
  • Diabetic Coma
  • Diabetic Ketoacidosis
  • Disorders Of Sexual Differentiation
  • Disorders Of Water Balance
  • Ectopic Hyperparathyroidism
  • Elevated Acth
  • Elevated Growth Hormone
  • Endocrine Disorders
  • Familial Hypocalciuric Hypercalcemia
  • Feminizing Syndrome
  • Glucocorticoid Deficiency
  • Gonadal Dysgenesis
  • Grave's Disease
  • Growth Disorders
  • Growth Failure
  • Growth Hormone Abnormalities
  • Growth Hormone Deficiency
  • Gynecomastia
  • Hashimoto Thyroiditis
  • History Of Pituitary Mass
  • Hyperaldosteronism
  • Hypercalcemia
  • Hyperglycemia
  • Hyperparathyroidism
  • Hyperthyroidism
  • Hypo Thalamic Pituitary Disorder
  • Hypocalcemia
  • Hypoglycemia
  • Hypogonadism
  • Hypoparathyroidism
  • Hypopituitarism
  • Hypothyroidism
  • Insulin Resistance
  • Islet Cell Hyperplasia
  • Juvenile Diabetes
  • Low T3
  • Low T4
  • Maturity Onset Diabetes Of The Young
  • Mccune Albright Syndrome
  • Metabolic Abnormalities
  • Metabolic Disorders (INHERITED)
  • Metabolic Syndrome
  • Morbid Obesity
  • Multiple Endocrine Neoplasia
  • Multiple Endocrine Neoplasia Type 1
  • Multiple Endocrine Neoplasia Type 2
  • Multiple Endocrine Neoplasia Type 2A
  • Multiple Endocrine Neoplasia Type 2B
  • Myxedema
  • Nodular Goiter
  • Non Toxic Goiter
  • Ovarian Failure
  • Panhypopituitarism
  • Parathyroid Adenoma
  • Parathyroid Cancer
  • Parathyroid Disease
  • Parathyroid Mass
  • Pheochromocytoma
  • Pituitary Adenoma
  • Pituitary Disorders
  • Pituitary Tumor
  • Polycystic Ovary Syndrome
  • Polyglandular Autoimmune Syndrome
  • Precocious Puberty
  • Premature Adrenarche
  • Pseudohermaphroditism
  • Pseudohypoparathyroidism
  • Rickets
  • Salt Balance Disorders
  • Secondary Hyperaldosteronism
  • Testicular Dysfunction
  • Testosterone Deficiency
  • Thelarche
  • Thyroid Cancer
  • Thyroid Cyst
  • Thyroid Disorder
  • Thyroid Nodule
  • Thyroiditis
  • Thyrotoxic Exophthalmos
  • Thyrotoxicosis
  • Turner Syndrome
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Virilizing Syndrome
  • Vitamin D Deficiency
  • Weight Problem
Show All Show Less

Procedures I perform

  • Diabetes Education
  • Insulin Pump
  • Supprelin Implant
  • Thyroid Function Blood Panel
Show All button Press enter to expand Show Less

Practice locations

Distance from Change LocationEnter your Location

4200 Wisconsin Avenue Northwest
Suite 400
Washington, DC, 20016


Fax 877-680-5502

Get Directions

miles away

Fax 877-680-5502


MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.

  • List of insurance plans we accept
    • United Optimum Choice Preferred (POS) & OCI Direct (HMO)
    • MedStar Family Choice DC Healthcare Alliance
    • CareFirst MedStar PPO
    • D-SNP)
    • Medicaid - Virginia
    • United MD IPA Preferred (POS)
    • HumanaChoice PPO
    • CareFirst NASCO
    • Carefirst Blue Preferred PPO
    • Innovation Health: Open POS Plus
    • Virginia Premier
    • Aetna Traditional Choice (PPO)
    • Innovation Health: PPO
    • Cigna EPO
    • Kaiser Medicare Plus
    • Carefirst BlueChoice Open Access
    • United Erickson Advantage Plans
    • Cigna Network Open Access
    • Tricare East Select
    • Medicaid - Maryland
    • United Choice
    • Innovation Health: Network Only Plus
    • Cigna True Choice Medicare (PPO)
    • United AARP Medicare Complete
    • Innovation Health: POS
    • Kaiser Select-Added Choice
    • Kaiser HMO Plus and DHMO Plus Member
    • Aetna Choice POS & Choice POS II
    • Aetna Managed Choice (POS)
    • CareFirst (NCA) Indemnity
    • Aetna HMO
    • Medicaid - District of Columbia
    • HumanaChoice Honor’s plan PPO
    • United Community Plan - Maryland Health Choice Program
    • Carefirst Healthy Blue (HMO/POS)
    • CareFirst BC/BS Advantage Core/Enhanced
    • HealthyBlue PPO
    • Cigna POS/Network POS
    • Kaiser Maryland Medicaid MCO
    • Health Services for Children with Special Needs (HSCSN)
    • CareFirst Group Medicare Advantage
    • Maryland Point of Service Plan (MPOS)
    • United Choice Plus
    • United Group Medicare Advantage Plans
    • United Golden Rule
    • United Optimum Choice
    • Kaiser Select
    • WellPoint Maryland
    • United Select Plus (POS)
    • Aetna Select HMO/HealthFund/Health Network
    • Tricare East Prime
    • United Nursing Home Plan (C-SNP
    • Private Health Care Systems (PHCS) (PPO)
    • United Select HMO - EPO/NPP
    • United MD IPA (HMO)
    • CareFirst Administrators
    • Aetna Quality Point of Service (POS)
    • Cigna HMO Open Access
    • Cigna PPO and PPO Plus
    • Aetna Signature Administrator PPO/TPA
    • Kaiser Signature
    • Kaiser Permanente Signature-Added Choice
    • United Medicare Advantage DSNP District of Columbia
    • Cigna True Choice Plus Medicare (PPO)
    • Aetna Student Health Insurance
    • WellPoint Maryland - Maryland Health Choice
    • Federal Employee Program (Std/Basic PPO/Blue Focus)
    • CareFirst Blue Card Program (Out-of-area BCBS plans)
    • Innovation Health: HMO & EPO Plus
    • Traditional Medicare Fee for Service
    • MedStar Family Choice DC Healthy Families
    • Tricare for Life East
    • United Student Resources
    • Cigna Alliance Medicare (HMO) |
    • Kaiser Flexible Choice
    • Anthem Plus BCBS of VA HealthKeepers Plus
    • Choice Care Network/HUMANA (PPO)
    • United Core Essential (HMO)
    • Aetna Elect Choice/ Open Access (POS)
    • Beech Street PPO
    • Kaiser Medicare Advantage Signature and Select
    • Innovation Health: Open POS II
    • CareFirst MedStar Select PPO
    • Anthem (POS & Open Access POS) BCBS of VA HealthKeepers
    • I-SNP
    • Anthem HMO - BCBS of VA HealthKeepers
    • Cigna Achieve Medicare (HMO C-SNP)
    • Innovation Health: Open Network Only Plus
    • Aetna HMO-Open Access/Select OA
    • Aetna Open Choice (PPO)
    • Aetna HealthFund/Health Network Option OA
    • Innovation Health: Indemnity
    • Cigna TotalCare (HMO D-SNP)
    • Cigna POS Open Access & Open Access Plus
    • Police and Fire Clinic
    • Aetna Open HMO/Open HMO Option/Open EPO Plus
    • Carefirst BlueChoice HMO
    • Innovation Health: POS Plus
    • United Options (PPO) (includes Empire PPO)
    • United Navigate
    • CareFirst Maryland Indemnity or PPO
    • Cigna HMO & Network (HMO)
    • Aetna Managed Choice Open Access (POS)
    • United Mamsi Life & Health
    • Tricare Reserve Select
    • Carefirst EPO
    • UnitedHealthcare Individual Exchange Plans
    • Aetna Elect Choice/ EPO (Aetna Health Fund)
    • Cigna Indemnity
    • Carefirst BlueChoice Opt Out Open Access
    • Veterans Affairs Community Care Network (VA CCN)
    • United GEHA (for all other states) Compass Rose
    • Cigna Preferred Medicare
    • Carefirst BlueChoice Opt Out Plus Open Access (POS)
    • CareFirst Group Medicare Advantage prescription drug benefit (PPO)
    • Cigna Choice Fund PPO
    • Aetna Medicare Advantage HMO & PPO Plans
    • Veterans Affairs Community Care Network
    • Coventry Health Care of Virginia
    • MedStar Family Choice - Maryland Health Choice
    • Great-West Healthcare POS/CIGNA
    • First Health PPO
    • Coventry of Delaware HMO/PPO
    • Coventry Health Care National Network PPO


Board Certification: American Board of Pediatrics, Pediatrics

Board Certification: American Board of Pediatrics, Pediatric Endocrinology

Fellowship Program: National Institute of Health (2013)

Residency Program: Miami Childrens Hospital (2010)

Medical School: Aristotle Medical School (2002)


  • 2019: Most Outstanding Scientific Abstract Award, Medstar Health-Georgetown University Research Symposium
  • 2019: Oral presentation for the abstract “Effect of metformin on HDL proteome in youth with T1DM”, PAS conference 2019, Baltimore, MD
  • 2018: Oral presentation for the abstract “Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes”, ACTS conference 2018, Washington DC
  • 2017: Oral presentation for the abstract “Youth with type 1 diabetes have atherogenic lipoprotein particles which correlate with low insulin sensitivity”, ACTS conference 2017, Washington DC
  • 2015: Scholarship Award to attend the GHUCCTS Master Program of Science in Clinical and
  • Translational Research.
  • 2013: Special acknowledgment at the Presidential Poster Reception at Pediatric Endocrine Society Meeting “Catch up growth in pediatric patients after successful treatment of Cushings syndrome due to adrenal or pituitary tumor”.
  • 2012: The Endocrine Society travel award at ENDO
  • 2012: Outstanding Abstract Award Winner at ENDO: "A novel method for metabolic classification of polycystic ovary syndrome".
  • 2012: Presidential Poster Competition Award at ENDO 2012: “A novel method for metabolic classification of polycystic ovary syndrome".
  • 2012: NICHD Fellows Intramural Grants Supplement (FIGS) Award

News and publications

  1. Flokas ME, Zeymo A, Mete M , Anhalt H, Rother KI, Gourgari E. Overweight and obese children with optimal control in the T1D Exchange Registry: How are they different from lean children with optimal control?: A cross-sectional registry analysis, Journal of Diabetes and its complications, in press January 2020
  2. Gourgari, E., Stafford, J. M., D'Agostino, R., Jr., Dolan, L. M., Lawrence, J. M., Mottl, A., . . . Dabelea, D. (2019). Association of metformin and statin medications with surrogate measures of cardiovascular disease in youth with type 1 diabetes: the SEARCH for diabetes in youth study. Ann Pediatr Endocrinol Metab, 24(3), 187-194. doi:10.6065/apem.2019.24.3.187
  3. Miller, B. S., Spencer, S. P., Geffner, M. E., Gourgari, E., Lahoti, A., Kamboj, M. K., Sarafoglou, K. (2020). Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings. J Investig Med, 68(1), 16-25. doi:10.1136/jim-2019-000999
  4. Gourgari E, Junfeng Ma, Martin P. Playford, Nehal N. Mehta, Radoslav Goldman, Alan T. Remaley , Scott M. Gordon, Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case-control study. Cardiovasc Diabetol. 2019 Mar 28;18(1):43. doi: 10.1186/s12933-019-0846-9.
  5. Dey AK, Groenendyk J, Mehta NN, Gourgari E. The effect of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 agonists on cardiovascular disease in patients with type 2 diabetes. Clin Cardiol. 2019 Jan 12. doi: 10.1002/clc.23152. [Epub ahead of print] Review’
  6. Gourgari E, Playford MP, Campia U, Dey AK, Cogen F, Gubb-Weiser S, Mete M, Desale S, Sampson M, Taylor A, Rother KI, Remaley AT, Mehta NN. Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study. Cardiovasc Diabetol. 2018 Dec 19;17(1):158. doi: 10.1186/s12933-018-0802-0.
  7. Kahkoska AR, Shay CM, Couch SC, Crandell J, Dabelea D, Gourgari E, Lawrence JM, Liese AD, Pihoker C, Reboussin BA et al: Sociodemographic associations of longitudinal adiposity in youth with type 1 diabetes. Pediatric diabetes 2018, 19(8):1429-1440.
  8. Agiostratidou G, Anhalt H, Ball D, Blonde L, Gourgari E, Harriman KN, Kowalski AJ, Madden P, McAuliffe-Fogarty AH, McElwee-Malloy M et al: Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes care 2017, 40(12):1622-1630.
  9. Gourgari E, Dabelea D, Rother K: Modifiable Risk Factors for Cardiovascular Disease in Children with Type 1 Diabetes: Can Early Intervention Prevent Future Cardiovascular Events? Current diabetes reports 2017, 17(12):134.
  10. Gourgari E, Wilhelm EE, Hassanzadeh H, Aroda VR, Shoulson I: A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data. Journal of diabetes and its complications 2017, 31(12):1719-1727.
  11. Gourgari EA, Mete M, Sampson ML, Harlan DM, Remaley AT, Rother KI: Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes. Diabetes care 2017, 40(7):e88-e89.
  12. Gourgari E, Spanakis E, Dobs AS: Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome. International journal of women's health 2016, 8:381-387.
  13. Bandettini WP, Karageorgiadis AS, Sinaii N, Rosing DR, Sachdev V, Schernthaner-Reiter MH, Gourgari E, Papadakis GZ, Keil MF, Lyssikatos C et al: Growth hormone and risk for cardiac tumors in Carney complex. Endocrine-related cancer 2016, 23(9):739-746.
  14. Magee MF, Gourgari E, Youssef GA, Nassar CM: mHealth Real-Time Blood Glucose Monitoring Facilitates Glycemic Management. Journal of diabetes science and technology 2017, 11(1):172-173.
  15. Gourgari E, Lodish M, Keil M, Sinaii N, Turkbey E, Lyssikatos C, Nesterova M, de la Luz Sierra M, Xekouki P, Khurana D et al: Bilateral Adrenal Hyperplasia as a Possible Mechanism for Hyperandrogenism in Women With Polycystic Ovary Syndrome. The Journal of clinical endocrinology and metabolism 2016, 101(9):3353-3360
  16. Gourgari E, Lodish M, Shamburek R, Keil M, Wesley R, Walter M, Sampson M, Bernstein S, Khurana D, Lyssikatos C et al: Lipoprotein Particles in Adolescents and Young Women With PCOS Provide Insights Into Their Cardiovascular Risk. The Journal of clinical endocrinology and metabolism 2015, 100(11):4291-4298.
  17. Afshari A, Ardeshirpour Y, Lodish MB, Gourgari E, Sinaii N, Keil M, Belyavskaya E, Lyssikatos C, Chowdhry FA, Chernomordik V et al: Facial Plethora: Modern Technology for Quantifying an Ancient Clinical Sign and Its Use in Cushing Syndrome. The Journal of clinical endocrinology and metabolism 2015, 100(10):3928-3933.
  18. Faucz FR, Horvath AD, Azevedo MF, Levy I, Bak B, Wang Y, Xekouki P, Szarek E, Gourgari E, Manning AD et al: Is IGSF1 involved in human pituitary tumor formation? Endocrine-related cancer 2015, 22(1):47-54.
  19. Gourgari E, Lodish M, Keil M, Wesley R, Hill S, Xekouki P, Lyssikatos C, Belyavskaya E, De La Luz SM, Stratakis CA: Post-operative growth is different in various forms of pediatric Cushing's syndrome. Endocrine-related cancer 2014, 21(6):L27-31.
  20. Crocker MK, Gourgari E, Lodish M, Stratakis CA: Use of aromatase inhibitors in large cell calcifying sertoli cell tumors: effects on gynecomastia, growth velocity, and bone age. The Journal of clinical endocrinology and metabolism 2014, 99(12):E2673-2680.
  21. Gourgari E, Nella AA, Lodish M, Stratakis CA, Yanovski JA: Vitamin B12 deficiency in an adolescent girl with polycystic ovarian syndrome. European journal of obstetrics, gynecology, and reproductive biology 2014, 179:254.
  22. Lodish MB, Gourgari E, Sinaii N, Hill S, Libuit L, Mastroyannis S, Keil M, Batista DL, Stratakis CA: Skeletal maturation in children with Cushing syndrome is not consistently delayed: the role of corticotropin, obesity, and steroid hormones, and the effect of surgical cure. The Journal of pediatrics 2014, 164(4):801-806.
  23. London E, Rothenbuhler A, Lodish M, Gourgari E, Keil M, Lyssikatos C, de la Luz Sierra M, Patronas N, Nesterova M, Stratakis CA: Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implications. The Journal of clinical endocrinology and metabolism 2014, 99(2):E303-310.
  24. Salpea P, Horvath A, London E, Faucz FR, Vetro A, Levy I, Gourgari E, Dauber A, Holm IA, Morrison PJ et al: Deletions of the PRKAR1A locus at 17q24.2-q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing. The Journal of clinical endocrinology and metabolism 2014, 99(1):E183-188.
  25. Xekouki P, Mastroyiannis SA, Avgeropoulos D, de la Luz Sierra M, Trivellin G, Gourgari EA, Lyssikatos C, Quezado M, Patronas N, Kanaka-Gantenbein C et al: Familial pituitary apoplexy as the only presentation of a novel AIP mutation. Endocrine-related cancer 2013, 20(5):L11-14.
  26. Azevedo MF, Horvath A, Bornstein ER, Almeida MQ, Xekouki P, Faucz FR, Gourgari E, Nadella K, Remmers EF, Quezado M et al: Cyclic AMP and c-KIT signaling in familial testicular germ cell tumor predisposition. The Journal of clinical endocrinology and metabolism 2013, 98(8):E1393-1400.
  27. Crutchfield CA, Olson MT, Gourgari E, Nesterova M, Stratakis CA, Yergey AL: Comprehensive analysis of LC/MS data using pseudocolor plots. Journal of the American Society for Mass Spectrometry 2013, 24(2):230-237.
  28. Gourgari E, Saloustros E, Stratakis CA: Large-cell calcifying Sertoli cell tumors of the testes in pediatrics. Current opinion in pediatrics 2012, 24(4):518-522.
  29. Avgerinos DV, Kyriakopoulos CE, Konstantinopoulou S, Gourgari E, Lioutas V: Post-traumatic splenic cysts treated with laparoscopy: two case reports. Cases journal 2009, 2:7976

Ratings and reviews

  • Explanations the care provider gave you about your problem or condition

  • Extent to which the care provider listened to you

  • Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)

  • Care provider's efforts to include you in decisions about your care

  • Concern the care provider showed for your questions or worries

  • Likelihood of recommending this care provider to others

  • Feb 29, 2024

    Doctor Gourgari was totally unprepared for the visit and had no understanding of my daughter's history. She clearly walked in the door without having reviewed her chart, to include recent lab results from a week prior. She was late, condescending, and ill prepared for the appointment.

  • May 23, 2023

    Dr Gourgari was amazing- spent a lot of time getting to know us, our situation and coming up with a medical plan.

  • May 2, 2023

    She took her time in explaining things which I liked.